CN1105569C - Medicinal composition for stasis of blood - Google Patents
Medicinal composition for stasis of blood Download PDFInfo
- Publication number
- CN1105569C CN1105569C CN99100125A CN99100125A CN1105569C CN 1105569 C CN1105569 C CN 1105569C CN 99100125 A CN99100125 A CN 99100125A CN 99100125 A CN99100125 A CN 99100125A CN 1105569 C CN1105569 C CN 1105569C
- Authority
- CN
- China
- Prior art keywords
- portions
- radix
- blood
- root
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a medical composition for stasis of blood. Components with a weight proportion comprise 20 to 30 portions of angelica, 20 to 30 portions of rehmannia root, 30 to 40 portions of peach seed, 10 to 20 portions of safflower, 15 to 25 portions of fructus, 15 to 25 portions of red peony root, 10 to 25 portions of radix bupleuri, 5 to 10 portions of liquorice, 10 to 20 portions of platycodon root, 10 to 20 portions of angelica root, 10 to 15 portions of twotooth achyranthes root, 20 to 30 portions of olibanum, 20 to 30 portions of myrrh, 10 to 15 portions of scorpion, 10 to 15 portions of centipede, 10 to 15 portions of asarum herb and 10 to 15 portions of earthworm. The treatment of different diseases with same method is really realized by medical composition, and the present invention has the effects of treating various diseases by one prescription.
Description
The present invention relates to a kind of pharmaceutical composition that is used for syndrome of blood stasis, specifically the pharmaceutical composition that is prepared from by vegetable Chinese herbal medicine.
Syndrome of blood stasis is that the traditional Chinese medical science is long-pending not all right to the blood stasis of blood, the capable mistake degree of blood, the general name of the obstructed clinical pathological changes that causes of blood vessels.As coronary heart disease, myocardial infarction, thromboangiitis obliterans, cerebral infarction sequela, hemiplegia, numb limbs and tense tendons, puerperal rheumatic, Ru Repair-in, amenorrhea, intractable headache, hepatitis, hepatosplenomegaly, chronic bronchitis or the like disease, say with theory of Chinese medical science, be syndrome of blood stasis.The traditional Chinese medical science all adopts promoting blood circulation by removing blood stasis to the treatment of syndrome of blood stasis.People often are called treating different diseases with the same therapeutic principle.And in practical clinical,, generally all adopt different prescriptions for a certain specific syndrome of blood stasis.In honest and upright official's case, singly being used for gynecological's syndrome of blood stasis just has various prescriptions.The example blood stasis has damp and hot person with four thing dampness removing soup (fresh rehmannia charcoal, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Seem Lablab Album, Rhizoma Dioscoreae, Semen Coicis, Poria, Medulla Tetrapanacis), and blood stasis has turbid person to adopt accent flourish stomach Siberian cocklebur soup (Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Pollen Typhae, Rhizoma Atractylodis, Cortex Magnoliae Officinalis, Pericarpium Citri Reticulatae, Poria, Rhizoma Alismatis, Herba Lycopi, Herba Leonuri).And be used for cardiovascular system, the blood circulation promoting and blood stasis dispelling prescription of digestive system is then innumerable especially.So, use the activating blood and resolving stasis and treating syndrome of blood stasis generally speaking, be not treating different diseases with the same therapeutic principle truly.
Purpose of the present invention just provides a kind of fixedly pharmaceutical composition of prescription that has that can be used for multiple syndrome of blood stasis.
The object of the present invention is achieved like this: by weight, select Radix Angelicae Sinensis 20-30 part, Radix Rehmanniae 20-30 part, Semen Persicae 30-40 part, Flos Carthami 10-20 part, Fructus Aurantii 15-25 part, Radix Paeoniae Rubra 15-25 part, Radix Bupleuri 10-25 part, Radix Glycyrrhizae 5-10 part, Radix Platycodonis 10-20 part, Rhizoma Chuanxiong 10-20 part, cattle sunset 10-15 part, Olibanum 20-30 part, Myrrha 20-35 part, Scorpio 10-15 part, Scolopendra 10-15 part, Herba Asari, 10-15 part, Pheretima 10-15 part for use.
Among the present invention the best ratio range of each component be (by weight) Radix Angelicae Sinensis 23-27 part, Radix Rehmanniae 23-27 part, Semen Persicae 35-37 part, Flos Carthami 12-15 part, Fructus Aurantii 17-22 part, Radix Paeoniae Rubra 17-22 part, Radix Bupleuri 12-20 part, Radix Glycyrrhizae 7-8 part, Radix Platycodonis 12-17 part, Rhizoma Chuanxiong 12-17 part, cattle sunset 12-14 part, Olibanum 22-27 part, Myrrha 22-30 part, Scorpio 12-13 part, Scolopendra 12-13 part, Herba Asari 12-13 part, Pheretima 12-13 part.
Medicine of the present invention can be made decoction, capsule, tablet, oral liquor and other types of formulations.Wherein effectively simple with decoction.The concrete preparation method of decoction is: after above-mentioned each component is taken by weighing by its weight proportion requirement, except that Olibanum, Myrrha, will soak after all the other medicament mixed 20-30 minute, decoct and add Olibanum, Myrrha after 1 hour, boil again after 10 minutes and leave and take filtrate, medicinal residues boiled 30 minutes after adding water again, merge filtrate twice, decoction.
Medicine of the present invention can be used for treating the blood stasis type amenorrhea, puerperal rheumatic, nodules of the breast, chronic hepatitis, hepatosplenomegaly, intractable headache, be insomnia seek dreams, syndrome of blood stasis such as cardiopalmus, cerebral infarction sequela, hemiplegia, numb limbs and tense tendons, hypochondriac pain, hyperlipidemia, microcirculation are unusual.
Instructions of taking of the present invention is: oral meal, a twice-daily, each 100ml.
The obtained beneficial effect of medicine of the present invention is: realized real treating different diseases with the same therapeutic principle, promptly a side controls more.
Beneficial effect of the present invention has obtained checking in clinical practice.It below is the clinical practice data of medicine of the present invention.
One, clinical case is selected:
1, patient with angina pectoris
2, intractable headache patient
3, rheumatisant
4, amenorrhea patients
5, cerebral infarction sequela patient
6,, Ru Repair-in patient
7, chronic hepatitis patient
Two, diagnostic criteria:
1,1. purplish tongue or tongue body ecchymosis, petechia, Sublingual arteries and veins varicose blood stasis of traditional Chinese medical science standard.2. stationarity pain, or angor or abdominal pain with tenderness.3. the pathologic lump comprises 4. aberrant angiogenesis of internal organs enlargement, the varicosis of partes corporis humani's door, telangiectasis, vasospasm, lip and acrocyanasis, thrombosis, angiemphraxis.5. escape of blood from meridians and stagnate and hemorrhage after 6. 7. hesitant pulse or knot, generation or pulsus deletus of face, lip, gums and purple near the eyes black person of the blood stasis, melena, ecchymosis etc. that cause.
2, doctor trained in Western medicine standard: meet The General Logistics Department of PLA's Ministry of Public Health and compile " clinical disease diagnosis " according to treatment improvement standard.
Three, criterion: allly meet Western medicine diagnose standard person simultaneously more than having the listed binomial of traditional Chinese medical science standard.The clinical practice result is as follows:
One of important innovations point of the present invention is: reasonable recipe has good synergism between each component.The property of medicine focuses on " leading to ", makes QI and blood unobstructed, and long-pending dissipating blood stasis disappears, and logical and disease more.
| Classification | Average day number of drug administration | Improvement rate | Cure rate |
| Angina pectoris | 20 | 75％ | |
| Intractable headache | 10 | 21％ | 69％ |
| Rheumatic arthritis | 10 | 60％ | 20％ |
| Amenorrhea | 7 | 18％ | 82％ |
| Hemiplegia | 40 | 68％ |
Two of important innovations point of the present invention is: prescription is fixed, and it is wide to adapt to disease, and one can Zhiduo County's disease, is suitable for to popularize.
Three of innovative point of the present invention is weight proportion scope selected between each drug component, has guaranteed the good efficacy that this medicine one side controls more.
It below is the specific embodiment of medicine of the present invention.
Embodiment 1
1. take by weighing 5 kilograms in 10 kilograms of Radix Glycyrrhizaes of 10 kilograms of Scolopendras of 10 kilograms of Scorpio of 15 kilograms of Radix Bupleuri of 25 kilograms of Radix Paeoniae Rubra of 10 kilograms of Fructus Aurantiis of 30 kilograms of Flos Carthamis of 30 kilograms of Semen Persicaes of 20 kilograms of Radix Rehmanniae of Radix Angelicae Sinensis, 15 gram 15 kilograms of Radix Platycodoniss of 15 kilograms of Pheretimas of Herba Asari
2. the said medicine component is placed to add water 10,000 L immersion 30 minutes in the container, decocted 1 hour, add 20 kilograms of Olibanums, Myrrha boils 10 minutes for 25 kilograms again, and is overanxious, and filtrate is kept somewhere, medicinal residues add 5000 liters in water and boiled 30 minutes again, twice filtrate merges the back patient and uses 100ml at every turn, every day secondary.
Following embodiment 2-5, its preparation method are all with embodiment 1, and just the proportional quantity of component is different, but all can reach purpose of the present invention and effect.
Claims (2)
1, a kind of pharmaceutical composition that is used for syndrome of blood stasis is characterized in that said composition has following components in weight percentage: Radix Angelicae Sinensis 20-30 part, Radix Rehmanniae 20-30 part, Semen Persicae 30-40 part, Flos Carthami 10-20 part, Fructus Aurantii 15-25 part, Radix Paeoniae Rubra 15-25 part, Radix Bupleuri 10-25 part, Radix Glycyrrhizae 5-10 part, Radix Platycodonis 10-20 part, Rhizoma Chuanxiong 10-20 part, cattle sunset 10-15 part, Olibanum 20-30 part, Myrrha 20-30 part, Scorpio 10-15 part, Scolopendra 10-15 part, Herba Asari 10-15 part, Pheretima 10-15 part.
2, pharmaceutical composition according to claim 1 is characterized in that the weight proportion of said component is: Radix Angelicae Sinensis 23-27 part, Radix Rehmanniae 23-27 part, Semen Persicae 35-37 part, Flos Carthami 12-15 part, Fructus Aurantii 17-22 part, Radix Paeoniae Rubra 17-22 part, Radix Bupleuri 12-20, part Radix Glycyrrhizae 7-8 part, Radix Platycodonis 12-17 part, Rhizoma Chuanxiong 12-17 part, cattle sunset 12-13 part, Olibanum 22-27 part, Myrrha 22-30 part, Scorpio 12-13 part, Scolopendra 12-13 part, Herba Asari 12-13 part, Pheretima 12-13 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99100125A CN1105569C (en) | 1999-01-14 | 1999-01-14 | Medicinal composition for stasis of blood |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99100125A CN1105569C (en) | 1999-01-14 | 1999-01-14 | Medicinal composition for stasis of blood |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1260193A CN1260193A (en) | 2000-07-19 |
| CN1105569C true CN1105569C (en) | 2003-04-16 |
Family
ID=5269807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99100125A Expired - Fee Related CN1105569C (en) | 1999-01-14 | 1999-01-14 | Medicinal composition for stasis of blood |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1105569C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772528A (en) * | 2012-07-11 | 2012-11-14 | 黄平县润发药业农民专业合作社 | Traditional Chinese medicine powder for treating apoplexy |
| CN103394028B (en) * | 2013-07-11 | 2015-02-04 | 卢颖 | Bruising internal injury first-aid Chinese herbal medicine composition and preparation method thereof |
| CN104027592A (en) * | 2014-05-21 | 2014-09-10 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating blood stasis type headache |
| CN104398763A (en) * | 2014-11-25 | 2015-03-11 | 杨文忠 | Traditional Chinese medicine for treating chong-ren incoordination type meridian stasis amenorrhea |
| CN104435335A (en) * | 2014-12-18 | 2015-03-25 | 王富 | Traditional Chinese medicine for treating cervical spondylosis, lumbar disc diseases, hyperplastic disease of breast and rheumatism and preparation method of traditional Chinese medicine |
| CN107158179A (en) * | 2017-04-11 | 2017-09-15 | 张拴芹 | Chinese patent drug bulk powder |
-
1999
- 1999-01-14 CN CN99100125A patent/CN1105569C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 《中原医刊》，1 1984-01-01 付中西， 血府逐瘀汤临床应用体会 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1260193A (en) | 2000-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine | |
| CN100506266C (en) | Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae | |
| CN103463528B (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN1151806C (en) | Capsule for curing cholecystitis | |
| CN101961477A (en) | Rheumatic bone ache medicine | |
| CN103784820A (en) | Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN103479929B (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN100333772C (en) | Medicine for treating digestive tract ulcer and stomach cercinoma prophase pathologic change | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN1876157A (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN103272143B (en) | Traditional Chinese medicine composition for treating acne | |
| CN101708297A (en) | Medicament for treating gout disease | |
| CN101129617A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN1105569C (en) | Medicinal composition for stasis of blood | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN1172672A (en) | Chinese medicinal herb composition for treating cancer | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN108014303A (en) | A kind of Chinese medicine preparation for treating Ru Repair-in and preparation method thereof | |
| CN100446798C (en) | Chinese herbal medicine decoction for treating B-type hepatitis and preparing method | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |